Aprea Therapeutics
APRE
APRE
41 hedge funds and large institutions have $10.4M invested in Aprea Therapeutics in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 9 closing their positions.
Holders
41
Holders Change
+2
Holders Change %
+5.13%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
9
Reduced
11
Closed
9
Calls
$507K
Puts
$255K
Net Calls
+$252K
Net Calls Change
+$1.18M
Top Buyers
| 1 |
PVI
1
Pura Vida Investments
New York
|
$1.25M |
| 2 |
2
Renaissance Technologies
New York
|
$809K |
| 3 |
3
Morgan Stanley
New York
|
$936K |
| 4 |
PP
4
PDT Partners
New York
|
$409K |
| 5 |
VF
5
Virtu Financial
New York
|
$120K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| $0 | 75 | +75 | New |
|
52
Wells Fargo
San Francisco,
California
| $0 | 95 | +95 | New |
|